Ignite Creation Date:
2025-12-24 @ 12:12 PM
Ignite Modification Date:
2025-12-27 @ 10:20 PM
Study NCT ID:
NCT01732861
Status:
COMPLETED
Last Update Posted:
2019-12-20
First Post:
2012-11-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-12-28
Start Date Type:
ACTUAL
Primary Completion Date:
2019-01-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-23
Completion Date Type:
ACTUAL
First Submit Date:
2012-11-14
First Submit QC Date:
None
Study First Post Date:
2012-11-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-19
Last Update Post Date:
2019-12-20
Last Update Post Date Type:
ACTUAL